Nordisk

Search:

A stronger Ozempic is coming. What to know about CagriSema, Novo Nordisk's new weight loss drug

found 18 Nov Quartz

qz.com › cagrisema-ozempic-weight-loss-drug-novo-nordisk-1851696433

This story seems to be about:

Novo Nordisk (NVO) — the company credited with ushering in the current weight-loss drug revolution when it launched its blockbuster diabetes treatment Ozempic in 2017 — is working on its next act, a weight-loss drug called CagriSema

A stronger Ozempic, a Boeing supplier in trouble, and a simpler Starbucks: Business news roundup

found 9 Nov Quartz

qz.com › ozempic-boeing-spirit-aerosystems-starbucks-trump-1851693471

This story seems to be about:

Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.

A new, stronger Ozempic is coming. Here’s what to know

found 6 Nov Quartz

qz.com › novo-nordisk-cagrisema-ozempic-1851691005

This story seems to be about:

Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.

Ozempic maker Novo Nordisk is working on a once-monthly weight-loss drug

found 4 Nov Quartz

qz.com › novo-nordisk-ascendis-pharma-glp-1-1851689087

This story seems to be about:

Novo Nordisk (NVO), the maker of blockbuster weight-loss and diabetes drugs Wegovy and Ozempic, has entered an agreement with Denmark-based Ascendis Pharma (ASND) to leverage the latter’s advanced drug delivery technology.